Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia. This evidence concerns the gene CSF3 and B-cell acute lymphoblastic leukemia.